DaVitaNYSE: DVA

DVA's strong revenue from dialysis patient services boosts its performance in the third quarter.

DaVita HealthCare (DVA) reported quarterly earnings of $2.59 per share, which is lower than the Zacks Consensus Estimate of $2.76 per share. This is also a decrease from the earnings of $2.85 per share from the same period last year.

On Tuesday, DaVita announced that its profits for the third quarter fell short of Wall Street's expectations due to increased costs for patient care.

DENVER, Oct. 29, 2024 /PRNewswire/ -- DaVita Inc. (NYSE: DVA) shared its financial and operational results for the quarter that ended on September 30, 2024. Javier Rodriguez, the CEO of DaVita Inc., stated, "We are committed to offering high-quality care to our patients while achieving strong financial results in the third quarter." He also expressed appreciation for the incredible strength shown by both patients and frontline caregivers during the recent severe storms.

The enhancement in RPT probably helped increase DaVita's revenue in the third quarter.

DENVER and SAN DIEGO, Oct. 23, 2024 /PRNewswire/ -- DaVita Clinical Research (DCR), a top company in kidney care research and a part of DaVita Inc., will share findings from five new research projects at the American Society of Nephrology (ASN)'s annual Kidney Week event happening now in San Diego, CA. DCR aims to enhance racial equity in organ transplants and improve important clinical quality indicators like hospitalizations, addressing critical challenges in nephrology that impact various communities.

DaVita HealthCare (DVA) finished the latest trading session at $163.16, which represents a 1% increase from the previous day's closing price.

Nephrologists are making significant improvements in patient care through a government program that focuses on high-need individuals. DaVita recently shared the positive results from their first year of working with nearly 1,300 nephrologists in the U.S. to provide better care for Medicare patients with kidney disease. The company appreciates the contributions of other specialty care providers who are also committed to enhancing health outcomes through value-based care.

In the latest trading session, DaVita HealthCare (DVA) finished at $164.82, showing a slight increase of 0.15% compared to the day before.